BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2437001)

  • 21. Production and characterization of monoclonal antibodies showing a different spectrum of reactivity to human breast tissue.
    Mandeville R; Giroux L; Lecomte J; Chausseau JP; Dumas F; Ajdukovic I; Vidal D; Boury F
    Cancer Detect Prev; 1987; 10(1-2):89-100. PubMed ID: 2436777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of tumour antigens in sera of patients with hepatocellular carcinoma using monoclonal antibodies.
    Wong LY; Chan SH; Oon CJ
    Asian Pac J Allergy Immunol; 1990 Dec; 8(2):83-6. PubMed ID: 1965408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in the gene expression of the hepatitis B virus in PLC-PRF-5 cells of human hepatocarcinoma during their acquisition of drug resistance].
    Tugizov ShM; Savchenkova IP; Grabovskaia IL; Kushch AA
    Vopr Virusol; 1992; 37(5-6):238-41. PubMed ID: 1337803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.
    Minden P; McClatchy JK; Wainberg M; Weiss DW
    J Natl Cancer Inst; 1974 Nov; 53(5):1325-31. PubMed ID: 4139280
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombinant human interleukin 1 alpha is cytotoxic for and increases surface expression of HLA-A,B,C antigens of a human hepatoma cell line, PLC/PRF/5.
    Yoshioka K; Fuji A; Tahara H; Arao M; Kakumu S
    Immunobiology; 1989 Feb; 178(4-5):380-9. PubMed ID: 2541069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunofluorescence detection of liver cell membrane autoantibodies using PLC/PRF/5 cells.
    de Koning RW; Daemen M; Schutte B; Geertzen HG; Blijham GH; Bosman FT
    Eur J Clin Invest; 1985 Apr; 15(2):64-8. PubMed ID: 2986983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW; Lee J; Stone MJ
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new murine monoclonal antibody against human hepatoma.
    Stein R; Wang ZF; Sharkey RM; Klein KM; Goldenberg DM
    Hybridoma; 1991 Apr; 10(2):255-67. PubMed ID: 1651901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of HLA class I antigens on hepatocytes in liver disease.
    Fukusato T; Gerber MA; Thung SN; Ferrone S; Schaffner F
    Am J Pathol; 1986 May; 123(2):264-70. PubMed ID: 2422944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human hepatocellular carcinoma and hepatoblastoma cell lines by deferoxamine.
    Tabor E; Kim CM
    J Med Virol; 1991 May; 34(1):45-50. PubMed ID: 1715897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accumulation of highly acidic sulfated glycosphingolipids in human hepatocellular carcinoma defined by a series of monoclonal antibodies.
    Hiraiwa N; Fukuda Y; Imura H; Tadano-Aritomi K; Nagai K; Ishizuka I; Kannagi R
    Cancer Res; 1990 May; 50(10):2917-28. PubMed ID: 2159366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibody recognizing human melanoma-carcinoma cross-reacting oncofetal antigen epitopically associated with carcinoembryonic antigen.
    Liao SK; Kwong PC; Clarke BJ; Dent PB; Ryan ED; Khosravi MJ; Laferte S; Krantz MJ
    J Natl Cancer Inst; 1985 May; 74(5):1047-58. PubMed ID: 2582173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A live cell enzyme-linked immunosorbent assay for detecting human hepatoma membrane antigens.
    Gaffar SA; Li Z; Epstein AL
    Hybridoma; 1989 Jun; 8(3):331-6. PubMed ID: 2545598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies to intermediate filament proteins of human cells: unique and cross-reacting antibodies.
    Gown AM; Vogel AM
    J Cell Biol; 1982 Nov; 95(2 Pt 1):414-24. PubMed ID: 6183272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen.
    Shouval D; Wands JR; Zurawski VR; Isselbacher KJ; Shafritz DA
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):650-4. PubMed ID: 6952217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B surface antigen produced by a human hepatoma cell line.
    MacNab GM; Alexander JJ; Lecatsas G; Bey EM; Urbanowicz JM
    Br J Cancer; 1976 Nov; 34(5):509-15. PubMed ID: 187208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new tumor-associated antigen useful for serodiagnosis of hepatocellular carcinoma, defined by monoclonal antibody KM-2.
    Kumagai Y; Chiba J; Sata T; Ohtaki S; Mitamura K
    Cancer Res; 1992 Sep; 52(18):4987-94. PubMed ID: 1381274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse monoclonal antibody (WI-MN-1) against malignant melanoma.
    Khan A; Grammer S; Chang D; Hill NO; Miller J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5868-72. PubMed ID: 6196109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human IgG3 monoclonal antibody directed to an unbranched repeating type 2 chain (Gal beta 1----4GlcNAc beta 1----3Gal beta 1----4GlcNAc beta 1----3Gal beta 1----R) which is highly expressed in colonic and hepatocellular carcinoma.
    Miyake M; Kohno N; Nudelman ED; Hakomori S
    Cancer Res; 1989 Oct; 49(20):5689-95. PubMed ID: 2551493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.